PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.24%
Revenue growth under 50% of RUN's 24.10%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-19.88%
Negative gross profit growth while RUN is at 613.19%. Joel Greenblatt would examine cost competitiveness or demand decline.
5.51%
EBIT growth below 50% of RUN's 27.53%. Michael Burry would suspect deeper competitive or cost structure issues.
5.24%
Operating income growth under 50% of RUN's 27.53%. Michael Burry would be concerned about deeper cost or sales issues.
18.05%
Net income growth under 50% of RUN's 148.54%. Michael Burry would suspect the firm is falling well behind a key competitor.
17.74%
EPS growth under 50% of RUN's 146.15%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
17.74%
Diluted EPS growth under 50% of RUN's 138.46%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.64%
Share count expansion well above RUN's 0.69%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.64%
Diluted share count expanding well above RUN's 0.53%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
18.87%
OCF growth under 50% of RUN's 72.84%. Michael Burry might suspect questionable revenue recognition or rising costs.
15.59%
FCF growth 50-75% of RUN's 22.26%. Martin Whitman would see if structural disadvantages exist in generating free cash.
256.51%
10Y revenue/share CAGR above 1.5x RUN's 83.40%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-49.79%
Negative 5Y CAGR while RUN stands at 83.40%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-36.12%
Negative 3Y CAGR while RUN stands at 83.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-3127.52%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.46%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-297.16%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-702.91%
Negative 10Y net income/share CAGR while RUN is at 247.27%. Joel Greenblatt sees a major red flag in long-term profit erosion.
66.53%
Below 50% of RUN's 247.27%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-413.33%
Negative 3Y CAGR while RUN is 247.27%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
30.14%
Equity/share CAGR of 30.14% while RUN is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-38.31%
Negative 5Y equity/share growth while RUN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
18.92%
Equity/share CAGR of 18.92% while RUN is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
20.97%
We show growth while RUN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.58%
Asset growth 1.25-1.5x RUN's 6.64%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
-3.73%
We have a declining book value while RUN shows 1.47%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
21.02%
Debt growth far above RUN's 14.69%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-3.96%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-13.40%
We cut SG&A while RUN invests at 1.35%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.